C
CRINETICS PHARMACEUTICALS INC
NASDAQ: CRNX (Crinetics Pharmaceuticals, Inc.)
Kemas kini terakhir: 24 minit lalu53.60
0.86 (1.63%)
| Penutupan Terdahulu | 52.74 |
| Buka | 52.28 |
| Jumlah Dagangan | 1,612,474 |
| Purata Dagangan (3B) | 754,625 |
| Modal Pasaran | 4,970,735,104 |
| Harga / Jualan (P/S) | 4.32 |
| Harga / Buku (P/B) | 6.70 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 26 Feb 2025 - 3 Mar 2025 |
| Margin Operasi (TTM) | -29,525.22% |
| EPS Cair (TTM) | -3.70 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -59.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 6.31% |
| Nisbah Semasa (MRQ) | 16.39 |
| Aliran Tunai Operasi (OCF TTM) | -199.81 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -115.20 M |
| Pulangan Atas Aset (ROA TTM) | -24.29% |
| Pulangan Atas Ekuiti (ROE TTM) | -40.26% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Crinetics Pharmaceuticals, Inc. | Menaik | Menaik |
AISkor Stockmoo
2.3
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 2.25 |
|
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 1.80% |
| % Dimiliki oleh Institusi | 94.72% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Driehaus Capital Management Llc | 30 Sep 2024 | 5,885,248 |
| Price T Rowe Associates Inc /Md/ | 30 Sep 2024 | 4,944,757 |
| Wellington Management Group Llp | 30 Sep 2024 | 4,459,691 |
| Fmr Llc | 30 Sep 2024 | 4,455,770 |
| Ecor1 Capital, Llc | 30 Sep 2024 | 4,288,120 |
| Jennison Associates Llc | 30 Sep 2024 | 2,793,614 |
| Paradigm Biocapital Advisors Lp | 30 Sep 2024 | 2,516,686 |
| Point72 Asset Management, L.P. | 30 Sep 2024 | 2,300,643 |
| Siren, L.L.C. | 30 Sep 2024 | 1,309,652 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 87.00 (JMP Securities, 62.31%) | Beli |
| Median | 81.00 (51.12%) | |
| Rendah | 74.00 (Citigroup, 38.06%) | Beli |
| Purata | 80.67 (50.50%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 57.74 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| JMP Securities | 16 Dec 2024 | 87.00 (62.31%) | Beli | 54.63 |
| 27 Sep 2024 | 80.00 (49.25%) | Beli | 50.75 | |
| Citigroup | 14 Nov 2024 | 74.00 (38.06%) | Beli | 59.66 |
| HC Wainwright & Co. | 13 Nov 2024 | 81.00 (51.12%) | Beli | 58.92 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |